Trial Profile
A Single-centre, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Dec 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- Sponsors Novo Nordisk
- 08 Dec 2017 Results assessing effects of liraglutide on gallbladder emptying, presented at the 2017 Congress of the International Diabetes Federation.
- 03 Mar 2017 Status changed from active, no longer recruiting to completed.
- 16 Nov 2016 Status changed from recruiting to active, no longer recruiting.